ArticleThe pharmacogenomics journal2018

Imatinib-induced ophthalmological side-effects in GIST patients are associated with the variations of EGFR, SLC22A1, SLC22A5 and ABCB1.

H-B Qiu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.